Phase II Trial of Concurrent Irinotecan Plus Cetuximab in Patients With Advanced Breast Cancer With Prior Anthracycline and/or Taxane-Containing Therapy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cetuximab; Irinotecan
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 13 Dec 2016 Biomarkers information updated
- 24 Feb 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 24 Oct 2006 Status change